Balcázar-Hernández Lourdes, Vargas-Ortega Guadalupe, González-Virla Baldomero, Cruz-López Martha, Rodríguez-Gómez Raúl, Espinoza-Pérez Ramón, Cuevas-García Carlos, Mendoza-Zubieta Victoria
Endocrinology Department, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Cuauhtémoc 330, Colonia Doctores, 06720 México City, Mexico.
Kidney Transplant Unit, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Cuauhtémoc 330, Colonia Doctores, 06720 México City, Mexico.
Int J Endocrinol. 2020 Mar 10;2020:6913506. doi: 10.1155/2020/6913506. eCollection 2020.
Bone mineral metabolism disease, which included persistent hyperparathyroidism, is common after successful kidney transplantation (KT) and is related with negative outcomes in kidney transplant recipients. There is a lack of information about bone mineral metabolism, persistent hyperparathyroidism, and its risk factors in Latin kidney transplant recipients (KTRs). : A retrospective study was conducted in 74 patients aged 18-50 years with evolution of 12 months after KT and estimated glomerular filtration rate (eGFR) >60 ml/min; biochemical data of bone mineral metabolism before and at 1, 3, 6, and 12 months of KT were registered. Age was 33 (IQR 27-37) years; 54% ( = 40) were men. Before KT, all patients had hyperparathyroidism, 40% ( = 30) hypocalcemia, 86% ( = 64) hyperphosphatemia, and 42% ( = 31) hyperphosphatasemia. After KT, an increase of calcium and a diminution of PTH, phosphorus, and alkaline phosphatase were corroborated (=0.001). All patients had hypovitaminosis D (deficiency: 91% ( = 67); insufficiency: 9% ( = 7)); 40% ( = 30) had persistent hyperparathyroidism at 12 months. Hyperphosphatasemia before KT (OR = 4.17 (95% CI: 1.21-14.44); =0.04), hyperparathyroidism at 6 months (OR = 1.84 (95% CI; 1.67-2.06); =0.02), hypovitaminosis D at 6 months (OR = 3.94 (95% CI: 1.86-17.9); =0.01), and hyperphosphatasemia at 6 months (OR = 1.47 (95% CI: 1.07-2.86); =0.03) were risk factors for persistent hyperparathyroidism at 12 months after KT. . Persistent hyperparathyroidism at 6 months, hypovitaminosis D, and hyperphosphatasemia are risk factors for persistent hyperparathyroidism at 1 year of KT in Latin population.
骨矿物质代谢疾病,包括持续性甲状旁腺功能亢进,在肾移植(KT)成功后很常见,并且与肾移植受者的不良预后相关。拉丁裔肾移植受者(KTRs)中关于骨矿物质代谢、持续性甲状旁腺功能亢进及其危险因素的信息匮乏。:对74例年龄在18 - 50岁、肾移植后12个月且估计肾小球滤过率(eGFR)>60 ml/min的患者进行了一项回顾性研究;记录了肾移植前以及肾移植后1、3、6和12个月时的骨矿物质代谢生化数据。年龄为33(四分位间距27 - 37)岁;54%(n = 40)为男性。肾移植前,所有患者均有甲状旁腺功能亢进,40%(n = 30)有低钙血症,86%(n = 64)有高磷血症,42%(n = 31)有碱性磷酸酶升高。肾移植后,证实钙升高且甲状旁腺激素、磷和碱性磷酸酶降低(P = 0.001)。所有患者均有维生素D缺乏(缺乏:91%(n = 67);不足:9%(n = 7));40%(n = 30)在12个月时有持续性甲状旁腺功能亢进。肾移植前碱性磷酸酶升高(比值比(OR)= 4.17(95%置信区间:1.21 - 14.44);P = 0.04)、6个月时甲状旁腺功能亢进(OR = 1.84(95%置信区间;1.67 - 2.06);P = 0.02)、6个月时维生素D缺乏(OR = 3.94(95%置信区间:1.86 - 17.9);P = 0.01)以及6个月时碱性磷酸酶升高(OR = 1.47(95%置信区间:1.07 - 2.86);P = 0.03)是肾移植后12个月时持续性甲状旁腺功能亢进的危险因素。. 6个月时的持续性甲状旁腺功能亢进、维生素D缺乏和碱性磷酸酶升高是拉丁裔人群肾移植1年时持续性甲状旁腺功能亢进的危险因素。